Suppression of myocardial 18F-FDG uptake by preparing patients with a high-fat, low-carbohydrate diet

被引:187
作者
Williams, Gethin [1 ]
Kolodny, Gerald M. [1 ]
机构
[1] Beth Israel Deaconess Med Ctr, Dept Radiol, Div Nucl Med, Boston, MA 02215 USA
关键词
cardiac imaging; contrast media; coronary artery disease; FDG; myocardium; patient preparation protocol; PET/CT;
D O I
10.2214/AJR.07.2409
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
OBJECTIVE. Myocardial F-18-FDG uptake in PET scans in patients prepared by the usual fasting protocol may result in difficulties in interpretation because variable uptake may yield false-positive results regarding mediastinal abnormalities. We aimed to analyze, retrospectively, the effect of diet on myocardial FDG uptake. MATERIALS AND METHODS. The "fasting" group comprised 101 consecutive patients before a clinical change in the patient preparation protocol. The "new diet" group comprised 60 consecutive patients after the clinical protocol change who were directed to consume a very high-fat, low-carbohydrate, protein-permitted (VHFLCPP) diet before FDG injection. All patients were given a questionnaire that was used to verify diet adherence. Non-adherers or patients failing to complete questionnaires were excluded from analysis. Myocardial uptake was evaluated by measuring the maximum standardized uptake value (SUVmax) in areas defined by CT as being cardiac. RESULTS. The average SUVmax for the fasting group (n = 101) was 8.8 +/- 5.7, and the average SUVmax for the VHFLCPP group (n = 60) was 3.9 +/- 3.6. The one-tailed Student's t test yielded a p value of < 0.00001. CONCLUSION. A VHFLCPP meal eaten 3-6 hours before FDG injection suppresses myocardial FDG uptake. This should facilitate definition of mediastinal abnormalities on FDG PET, particularly with stand-alone PET. Furthermore, this patient preparation protocol may permit the detection of biologically active coronary artery disease.
引用
收藏
页码:W151 / W156
页数:6
相关论文
共 13 条
[1]   Non-invasive imaging in the diagnosis and management of Takayasu's arteritis [J].
Andrews, J ;
Al-Nahhas, A ;
Pennell, DJ ;
Hossain, MS ;
Davies, KA ;
Haskard, DO ;
Mason, JC .
ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 (08) :995-1000
[2]   Free fatty acids repress the GLUT4 gene expression in cardiac muscle via novel response elements [J].
Armoni, M ;
Harel, C ;
Bar-Yoseph, F ;
Milo, S ;
Karnieli, E .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (41) :34786-34795
[3]  
Ben-Haim S, 2004, J NUCL MED, V45, P1816
[4]   MECHANISMS OF FATTY ACID-INDUCED INHIBITION OF GLUCOSE-UPTAKE [J].
BODEN, G ;
CHEN, XH ;
RUIZ, J ;
WHITE, JV ;
ROSSETTI, L .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (06) :2438-2446
[5]   Free fatty acids in obesity and type 2 diabetes:: defining their role in the development of insulin resistance and β-cell dysfunction [J].
Boden, G ;
Shulman, GI .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2002, 32 :14-23
[6]   Influence of blood glucose level, age and fasting period on non-pathological FDG uptake in heart and gut [J].
de Groot, M ;
Meeuwis, APW ;
Kok, PJM ;
Corstens, FHM ;
Oyen, WJG .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 (01) :98-101
[7]  
Frayn KN, 2003, BIOCHEM SOC T, V31, P1115, DOI 10.1042/BST0311115
[8]   Facilitative glucose transporter gene expression in human lymphocytes, monocytes, and macrophages: a role for GLUT isoforms 1, 3, and 5 in the immune response and foam cell formation [J].
Fu, YC ;
Maianu, L ;
Melbert, BR ;
Garvey, WT .
BLOOD CELLS MOLECULES AND DISEASES, 2004, 32 (01) :182-190
[9]  
Lum, 2000, Clin Positron Imaging, V3, P155, DOI 10.1016/S1095-0397(00)00067-4
[10]   Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography [J].
Rudd, JHF ;
Warburton, EA ;
Fryer, TD ;
Jones, HA ;
Clark, JC ;
Antoun, N ;
Johnström, P ;
Davenport, AP ;
Kirkpatrick, PJ ;
Arch, BN ;
Pickard, JD ;
Weissberg, PL .
CIRCULATION, 2002, 105 (23) :2708-2711